Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005080-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L148Yfs*16	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	14	35872461	35872461	G	-	14:g.35872461del	ENST00000216797.5:c.442del							42	3/6						75				0.4547						LUAD				1	Male	Former heavy		Matched	39.1487879046			NO	KRAS	IMPACT410	NO	MSKCC	0	Breast	Adenocarcinoma	Lung	YES	Tumor	965	YES	Metastasis		IV	NO	YES	70	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008324-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	F310Wfs*30	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	14	35871245	35871246	AC	-	14:g.35871245_35871246del	ENST00000216797.5:c.927_928del							15	6/6						76				0.2909						LUAD				1	Female	Never		Matched	14.6807954642			NO	ARAF	IMPACT410	NO	MSKCC	0	Brain	Adenocarcinoma	Lung	YES	Tumor	1033	YES	Metastasis		IV	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009614-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I120Dfs*9	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Ins	INS	Diploid		SOMATIC	NA	MSKCC	14	35872546	35872547	-	A	14:g.35872546_35872547insA	ENST00000216797.5:c.356dup							23	3/6						44				0.1111						LUAD				1	Male	Former heavy		Matched	22.5105530451			NO	MET_AMP	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	562	YES	Metastasis		IIIB	NO	YES		AWD																													
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0005898-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	D208dup	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Ins	INS	Diploid		SOMATIC	Unknown	MSKCC	14	35871987	35871988	-	CAT	14:g.35871987_35871988insCAT	ENST00000216797.5:c.623_625dup	0.19		328	1393		805	4	4/6						71		YES		0.1835						LUSC		12.53		1	Female			Matched	3.91487879046					IMPACT410																							1:Progressed																	0.18	Commercial	2	3.773584906		Never	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003055-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E6K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.5;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	35873835	35873835	C	T	14:g.35873835C>T	ENST00000216797.5:c.16G>A							13	1/6		Uncertain_significance	rs923187160			57		NO		0.1110						LUAD				1	Male	Never			14.4190189078			NO	ERBB2_WT_AMP	IMPACT341	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	885	YES	Metastasis		IV	NO	YES	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009017-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	W66C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: possibly_damaging, score: 0.525	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	14	35873653	35873653	C	G	14:g.35873653C>G	ENST00000216797.5:c.198G>C							34	1/6						75				0.1702						LUAD				1	Male	Former heavy		Matched	33.2764697189			NO	ERBB2_WT_AMP	IMPACT410	NO	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1097	NO	Metastasis		IV	NO	YES	40	AWD																													
